BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 6881016)

  • 1. Adverse effects of class I antiarrhythmic drugs.
    Caron J; Libersa C
    Drug Saf; 1997 Jul; 17(1):8-36. PubMed ID: 9258628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.
    Brogden RN; Todd PA
    Drugs; 1987 Aug; 34(2):151-87. PubMed ID: 3304965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance and discordance of drug responses in atrioventricular reentrant tachycardia.
    Bauernfeind RA; Swiryn S; Petropoulos AT; Coelho A; Gallastegui J; Rosen KM
    J Am Coll Cardiol; 1983 Aug; 2(2):345-50. PubMed ID: 6863767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of antiarrhythmic drug concentrations determined during electrophysiologic drug testing in patients with inducible tachycardias.
    Berry NS; Bauman JL; Gallastegui JL; Bauma W; Beckman KJ; Hariman RJ
    Am J Cardiol; 1988 Apr; 61(11):922-4. PubMed ID: 3354470
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
    Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients.
    Bauernfeind RA; Swiryn SP; Strasberg B; Palileo E; Scagliotti D; Rosen KM
    Am Heart J; 1982 Jun; 103(6):941-9. PubMed ID: 7081034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible sustained ventricular tachycardia refractory to individual class I drugs: effect of adding a second class I drug.
    Duffy CE; Swiryn S; Bauernfeind RA; Strasberg B; Palileo E; Rosen KM
    Am Heart J; 1983 Sep; 106(3):450-8. PubMed ID: 6881016
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias.
    Greenspan AM; Spielman SR; Horowitz LN
    Pacing Clin Electrophysiol; 1986 Jul; 9(4):565-76. PubMed ID: 2426675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.
    Kim SY; Benowitz NL
    Drug Saf; 1990; 5(6):393-420. PubMed ID: 2285495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of supraventricular tachycardias.
    Goldreyer BN
    Annu Rev Med; 1975; 26():219-28. PubMed ID: 1096759
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.